Multiple prion types in the same brain
Is a molecular diagnosis of CJD possible?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Transmissible spongiform encephalopathies (TSEs) are rare neurologic disorders that bear some resemblance to more common neurodegenerative conditions, such as Alzheimer’s disease and Parkinson’s disease. TSEs, however, are transmissible, whereas there is no convincing evidence that AD or PD are caused by transmissible agents.1 Conversely, TSEs, AD, and PD are all associated with progressive accumulation of fibrillar proteins in the brain. In TSE, most evidence suggests that the prion protein (PrP) is the cause of the disease and the transmissible agent.2 In AD, two types of fibrillar proteins are involved; extracellular amyloid deposits composed of Aβ, a proteolytic fragment of the amyloid precursor protein, and intracellular neurofibrillary inclusions composed of τ protein, a microtubule associated protein. In PD, intracellular fibrillar protein aggregates of synuclein form Lewy bodies, the histologic hallmark of PD. This tendency of normal cellular proteins to acquire novel attributes, which may be related to conformational changes and that favor formation of fibrillar, amyloid-like aggregates, may be a common mechanism in the pathogenesis of these disorders.3
The TSEs are most often sporadic disorders, but rare hereditary and iatrogenic variants are also recognized.1 The most common sporadic TSE is Creutzfeldt-Jakob disease (CJD). Hereditary forms include Gerstmann-Straüssler-Sheinker syndrome (GSS), familial CJD, and fatal familial insomnia (FFI). The most common iatrogenic form of TSE resulted from the administration of a growth hormone derived from cadaver pituitaries, a practice that is no longer used. Of great public health concern is the epidemic of bovine spongiform encephalopathy (BSE), which appears to be etiologically linked to a new …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Victoria Leavitt and Dr. Laura Hancock
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profilesV. Lewis, A. F. Hill, G. M. Klug et al.Neurology, July 11, 2005 -
Articles
Creutzfeldt–Jakob disease with a novel four extra-repeat insertional mutation in the PrP geneG. Rossi, G. Giaccone, L. Giampaolo et al.Neurology, August 08, 2000 -
Articles
Basis of phenotypic variability in sporadic Creutzfeldt–Jakob diseaseC. Tranchant, L. Geranton, C. Guiraud–Chaumeil et al.Neurology, April 01, 1999 -
Expedited Publication
A subtype of sporadic prion disease mimicking fatal familial insomniaP. Parchi, S. Capellari, S. Chin et al.Neurology, June 01, 1999